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Title 
Recruiting speech and language therapy departments in Scotland to deliver two 
routine NHS interventions for people with Parkinson’s disease as part of a 
randomised controlled trial (PD COMM) 
Abstract (max 500 words) 
Services and patients lack high quality evidence of effectiveness of speech and 
language therapy intervention for people with Parkinson’s disease. The PD COMM 
trial is designed to provide best evidence around effectiveness, cost-effectiveness 
and implementation of Lee Silverman Voice Treatment and other standard NHS 
intervention tailored to clients’ individual needs. Recruiting the 546 participants 
depends first on engaging over 40 speech and language therapy departments 
across the UK as enthusiastic clinical collaborators. By reporting on this work-in-
progress in relation to Scotland, we hope to encourage speech and language 
therapists to reflect on the wider implications of becoming involved (or not) with 
large-scale research studies. 
Speech and language therapists’ key role in the trial is to offer the two interventions 
to randomised patients, and to complete study paperwork and interviews about their 
intervention. The opportunity to participate in this type of study is rare. PD COMM is 
a large pragmatic UK randomised controlled trial with an integral process evaluation, 
funded by the National Institute for Health Research Health Technology Assessment 
Programme. People with Parkinson’s disease were involved in the design, it was 
based on a successful pilot (Sackley et al., submitted), and benefits for therapists 
include free training and supported continuing professional development. However, 
departments have many demands on their time, and we cannot take for granted that 
therapists will consider participating in a randomised controlled trial to be in the best 
interests of their patients, themselves, their departments, or their profession. 
A quarter of randomised controlled trials are stopped due to poor recruitment. While 
there is a growing body of research evidence around improving recruitment of 
patients, there is little to support decision-making for engaging departments who will 
provide the therapy interventions. A systematic review of the reasons for poor 
recruitment in discontinued trials suggested most were preventable (Briel et al., 
2016). Among these was prejudice against effectiveness of the trial interventions, 
including concerns around equipoise, professional autonomy, representation of 
current practice, and impact on patients and professional-patient relationships. 
This poster outlines how we have used evidence from the literature, previous 
experience, and feedback from the therapists we approached to develop and refine a 
responsive strategy for engaging speech and language therapy departments in 
Scotland in the PD COMM trial. It will also include the most up-to-date information on 
PD COMM recruitment.  
Three learning outcomes  
 Attendees will reflect on their views about randomised controlled trials in 
speech and language therapy 
 Attendees will recognise that recruitment challenges contribute to research 
waste 
 Attendees will assess their own engagement with research studies 
Brief outline of your submission (50 words) 
This poster outlines how we have developed and refined a responsive strategy to 
engage speech and language therapy departments in Scotland as clinical 
collaborators delivering two speech and language therapy interventions for people 
with Parkinson’s disease in the PD COMM trial. 
Three key words 
Randomisation, Recruitment, Collaboration 
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Research (speech and language therapy research contributing new knowledge) 
Related to conference aim:  
Working with decision makers and budget holders to understand how speech and 
language therapy supports delivery of key priorities at national, service, population 
and individual levels 
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